These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15711040)

  • 41. Evaluation of a polynephron dialysis membrane considering new aspects of biocompatibility.
    Martínez-Miguel P; de Sequera P; Albalate M; Medrano D; Sánchez-Villanueva R; Molina A; Sousa F; Benito J; Nuñez J; Vozmediano C; Aragoncillo I; Barril G; Rodríguez-Puyol D; Pérez-García R; López-Ongil S
    Int J Artif Organs; 2015 Jan; 38(1):45-53. PubMed ID: 25633893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The biocompatibility and bioactivity of hemodialysis membranes: their impact in end-stage renal disease.
    Kohlová M; Amorim CG; Araújo A; Santos-Silva A; Solich P; Montenegro MCBSM
    J Artif Organs; 2019 Mar; 22(1):14-28. PubMed ID: 30006787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of Biocompatibility of Membranes in Online Hemodiafiltration.
    Ojeda R; Arias-Guillén M; Gómez M; Vera M; Fontseré N; Rodas L; Filella X; Reverter JC; Lozano F; Villamor N; Maduell F
    Blood Purif; 2020; 49(4):400-408. PubMed ID: 31865336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Markers and possible uremic toxins: Japanese experiences.
    Kinugasa E
    Contrib Nephrol; 2011; 168():134-138. PubMed ID: 20938133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodialysis-associated induction of cytokines.
    Lonnemann G; Haubitz M; Schindler R
    Blood Purif; 1990; 8(4):214-22. PubMed ID: 2085429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biocompatibility of Hemodiafilters.
    Tomo T
    Contrib Nephrol; 2017; 189():210-214. PubMed ID: 27951570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of continuous hemodiafiltration on IL-6, TNF-alpha, C3a, and TCC in patients with SIRS/septic shock using two different membranes.
    Braun N; Rosenfeld S; Giolai M; Banzhaf W; Fretschner R; Warth H; Weinstock C; Deppisch R; Erley CM; Müller GA
    Contrib Nephrol; 1995; 116():89-98. PubMed ID: 8529388
    [No Abstract]   [Full Text] [Related]  

  • 48. Protein layer on hemodialysis membranes: a new immunohistochemistry technique.
    Panichi V; Casarosa L; Gattai V; Bianchi AM; Andreini B; Migliori M; De Pietro S; Giovannini L; Palla R
    Int J Artif Organs; 1995 Jun; 18(6):305-8. PubMed ID: 8593964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.
    Lorenzen J; David S; Bahlmann FH; de Groot K; Bahlmann E; Kielstein JT; Haller H; Fliser D
    PLoS One; 2010 Jul; 5(7):e11477. PubMed ID: 20628606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer?
    Ward RA
    Semin Dial; 2011; 24(1):65-71. PubMed ID: 21323999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients.
    Zhang DL; Liu J; Cui WY; Ji DY; Zhang Y; Liu WH
    Ren Fail; 2011; 33(7):682-91. PubMed ID: 21787159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction.
    Girndt M; Lengler S; Kaul H; Sester U; Sester M; Köhler H
    Am J Kidney Dis; 2000 Jan; 35(1):95-104. PubMed ID: 10620550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biocompatibility parameters of different dialysis membranes assessed during systemic inflammation.
    Gueler F; Gwinner W; Schiborr C; Martin M; Klos A; Kirsch T; Fiebeler A; Haller H; Fliser D
    Blood Purif; 2005; 23(3):196-202. PubMed ID: 15711040
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.